Brief: Integra Lifesciences Q4 Adjusted EPS USD 0.89 Vs. IBES Estimate USD 0.9
28/02/2024 11:00
Feb 28 (Reuters) - Integra Lifesciences Q4 adjusted net income USD 69.1 million. * Q4 adjusted EBITDA USD 100.5 million * Q4 EPS USD 0.25 * Q4 revenue USD 397 million vs. IBES estimate USD 399.3 million * outlook FY revenue USD 1,603-1,618 million
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes